Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)
- Citation:
- Ann Oncol vol 20 (3) 449-453
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 548
- Children:
- None
- Pharmas:
- Grants:
- CA- 35113, CA-37404, CA-35431, CA-35090, CA-35195, CA-35103, CA-25224, CA-60276, CA-63848, CA-35415, CA-37417, CA-35272, CA-35101, CA- 35269, CA-15083, CA-63849
- Corr. Author:
- Authors:
- V. Roy B. R. LaPlant G. G. Gross C. L. Bane F. M. Palmieri
- Networks:
- Study
- NCCTG-0531
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- breast cancer, chemotherapy, gemcitabine, nab-paclitaxel